<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02643108</url>
  </required_header>
  <id_info>
    <org_study_id>2015/1238-31/2</org_study_id>
    <nct_id>NCT02643108</nct_id>
  </id_info>
  <brief_title>Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women</brief_title>
  <acronym>EVA</acronym>
  <official_title>Randomized Controlled Clinical Trial of Lateral Episiotomy Versus no Episiotomy in Vacuum Assisted Delivery in Non-parous Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nulliparous women with a live singleton pregnancy in cephalic presentation past 34&#xD;
      gestational weeks will be randomized to lateral episiotomy or no episiotomy when operative&#xD;
      vaginal delivery by vacuum extraction is indicated. Primary outcome is clinically diagnosed&#xD;
      obstetric anal sphincter injury (OASIS) of any degree.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study has started at Danderyd Hospital. Danderyd Hospital is a large teaching hospital&#xD;
      affiliated to the Karolinska Institute in Stockholm, Sweden. South General Hospital in&#xD;
      Stockholm, Uppsala University Hospital, Falun Hospital, Helsingborg Hospital, Växjö Hospital,&#xD;
      Umeå University Hospital, and Gothenburg University Hospital Östra have joined the trial&#xD;
      2017-2019.&#xD;
&#xD;
      Informed consent is collected from nulliparous women with a singelton, live fetus in cephalic&#xD;
      presentation, with a planned vaginal delivery and without previous gynecological surgery due&#xD;
      to incontinence or genital prolapse. Women can be approached at any time from gestational&#xD;
      week 18 until delivery, unless they are in severe pain or discomfort, there is not enough&#xD;
      time to consider the information, or any other reason not to obtain consent. The informed&#xD;
      consent form is kept at the receiving research department and a note of consent/no consent is&#xD;
      made in the obstetric medical file.&#xD;
&#xD;
      At indication for vacuum extraction, the patient's consent is confirmed verbally and&#xD;
      allocation is made by sealed opaque envelopes on the vacuum extraction equipment mobile cart.&#xD;
      Randomization is performed 1:1 in random permuted blocks generated by an external&#xD;
      organization (Karolinska Trial Alliance).&#xD;
&#xD;
      Lateral episiotomy is performed according to the intervention description. A reduction of&#xD;
      OASIS from 12.4% to 6.2% can be detected with 80% power and less than 5% risk of alpha-error&#xD;
      (p&lt;0.05) with 354 women in each group using Chi-square test comparing two independent&#xD;
      proportions in a two-sided test (3% missing outcome). A smaller reduction is clinically&#xD;
      valuable, although the risk-benefit relationship between receiving a prophylactic episiotomy&#xD;
      and the chance of an intact perineum may limit the feasibility of a larger trial in a setting&#xD;
      with a restrictive episiotomy policy. We have obtained ethical approval to randomise a total&#xD;
      of 1400 women, which enables us to detect a reduction in OASIS rate at VE from 12.4% to 7.8%&#xD;
      (p&lt;0.05). We will perform an interim analysis in order to exclude an unethically large&#xD;
      difference (p&lt;0.01) in primary outcome or serious adverse events at 350 randomized women.&#xD;
&#xD;
      Data is collected prospectively through Case Record Forms and the obstetric medical file&#xD;
      Obstetrix (Cerner Sverige AB), which covers approximately 98% of deliveries with complete&#xD;
      data, and the Swedish Pregnancy Register covering the whole of Sweden from 2015. Using a&#xD;
      weblink, questionnaires from the national Perineal Tear Register, are sent out electronically&#xD;
      for the follow-up of the study participants. In addition, questionnaires regarding birth&#xD;
      satisfaction (BSS-R and CEQ 2.0) are sent at 8 weeks after delivery. Questionnaires regarding&#xD;
      sexual function (FSFI and FSDS) and quality of life (Euro-QoL-5D) at delivery and after 12&#xD;
      months.&#xD;
&#xD;
      A follow-up from registers regarding mode of delivery and prevalence of episiotomy and OASIS&#xD;
      in subsequent births will be performed at 5 years and 10 years after the index birth.&#xD;
&#xD;
      A substudy takes place in Stockholm, Uppsala, and Helsingborg, where included (randomized)&#xD;
      women are examined at 6-12 months after delivery with 2D and 3D endovaginal and anal&#xD;
      ultrasound to detect levator and sphincter injuries, measure episiotomy scars, establish&#xD;
      POP-Q scores, and evaluate a new questionnaire for pelvic floor function after perineal&#xD;
      tears.&#xD;
&#xD;
      Another substudy takes place in Stockholm and Falun, where women who have been asked for&#xD;
      consent (both affirmative and non-affirmative responders) as well as midwives who have tried&#xD;
      to obtain consent, are invited to a qualitative interview study to explore the recruitment&#xD;
      experience of women and midwives.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The allocation will be masked during statistical analyses.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Obstetric anal sphincter injury</measure>
    <time_frame>1 hour</time_frame>
    <description>Rupture or tear of the external and/or internal anal sphincter at any degree (third and fourth degree perineal tear); International Classification of Diseases (ICD)-10 O70.2 or O70.3.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other degree of perineal or vaginal tear</measure>
    <time_frame>1 hour</time_frame>
    <description>Rupture, tear or hematoma in the perineum or vagina; International Classification of Diseases (ICD)-10 O70.0, O70.1, O70.9, O71.4-9.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal blood loss at delivery</measure>
    <time_frame>6 hours</time_frame>
    <description>Estimated blood loss in milliliters through weighing of sheets and drapes during and up to 6 hours after delivery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal scalp injury</measure>
    <time_frame>24 hours</time_frame>
    <description>Prevalence (number of patients) of scalp injury to the neonate after instrumental delivery, such as open wounds, cephalic hematoma, subgaleal hematoma, and intracranial hemorrhage, according to diagnose by neonatologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain experience</measure>
    <time_frame>1 day, 8 weeks, 1 year</time_frame>
    <description>VAS (0-10) estimated pain through questionnaire at baseline (first days post partum), 8 weeks and 12 months after delivery and at 8 weeks through questionnaires: number of days using analgetic medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birthing experience</measure>
    <time_frame>8 weeks</time_frame>
    <description>Questionnaire at 8 weeks after delivery regarding patient satisfaction using the Birth Satisfaction Scale Revised (short form) and the Childbirth Experience Questionnaire 2.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal incontinence</measure>
    <time_frame>8 weeks, 1 year, and 5 years</time_frame>
    <description>Questionnaire at baseline, 8 weeks, 1 year, and 5 years after delivery through the Swedish Obstetrical Tear Register regarding anal continence function (Wexner score based).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>1 year and 5 years</time_frame>
    <description>Questionnaire at baseline (first day post partum), 1 year, and 5 years after delivery through the Swedish Obstetrical Tear Register, as well as FSFI and FSDS Questionnaires.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic organ prolapse symptoms</measure>
    <time_frame>1 year and 5 years</time_frame>
    <description>Questionnaire at baseline, 1 year, and 5 years after delivery through the Swedish Obstetrical Tear Register regarding symptoms of pelvic organ prolapse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life score</measure>
    <time_frame>1 year and 5 years</time_frame>
    <description>Assessment of quality of life by questionnaire at baseline, 1 year, and 5 years using the Euro-QoL-5D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery in subsequent birth</measure>
    <time_frame>5 years and 10 years</time_frame>
    <description>Register data will be extracted from the Swedish Pregnancy Register.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of obstetric anal sphincter injury in subsequent birth</measure>
    <time_frame>5 years and 10 years</time_frame>
    <description>Register data will be extracted from the Swedish Pregnancy Register.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of episiotomy in subsequent birth</measure>
    <time_frame>5 years and 10 years</time_frame>
    <description>Register data will be extracted from the Swedish Pregnancy Register.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">710</enrollment>
  <condition>Pelvic Floor Disorders</condition>
  <condition>Fecal Incontinence</condition>
  <condition>Dystocia</condition>
  <condition>Fetal Hypoxia</condition>
  <arm_group>
    <arm_group_label>Lateral episiotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lateral episiotomy (left or right) is performed by the attending physician or assisting midwife at crowning of the fetal head in operative vaginal delivery by vacuum extraction. Regular manual perineal support is applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No episiotomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No episiotomy is performed during operative vaginal delivery, unless vitally indicated (for example severe fetal distress). The woman may tear spontaneously. Regular manual perineal support is applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lateral episiotomy</intervention_name>
    <description>When the woman is randomized to episiotomy, lateral episiotomy is performed with scissors on the left or right side of the vaginal opening. Origin of incision is 1.0 - 3.0 cm from the midline/posterior forchette and is cut 3.0 cm or more towards the ischial tuberosity at an angle of 60 degrees from the midline.</description>
    <arm_group_label>Lateral episiotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Nulliparous women,18 years old or more, able to give written informed consent in&#xD;
             Swedish or English, with a live singleton pregnancy, in a cephalic presentation over&#xD;
             34 completed gestational weeks with a medical indication of vacuum extraction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous vaginal or perineal surgery for incontinence or genital prolapse, any&#xD;
             contra-indication to vacuum extraction (ie fetal disorder or malformation).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophia Brismar Wendel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet Danderyd Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophia Brismar Wendel, MD, PhD</last_name>
    <phone>+46812358564</phone>
    <email>sophia.brismar-wendel@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Persson, MD, PhD</last_name>
    <phone>+46812355000</phone>
    <email>maria.k.persson@sll.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Falun Hospital</name>
      <address>
        <city>Falun</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Hesselman, MD, PhD</last_name>
      <phone>004623492000</phone>
      <email>susanne.hesselman@ltdalarna.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Östra Hospital Gothenburg University</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Friberg, M.D.</last_name>
      <email>hanna.friberg@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Åsa Leijonhufvud, MD, PhD</last_name>
      <phone>0046424062227</phone>
      <email>asa.leijonhufvud@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danderyd Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophia Brismar Wendel, MD, PhD</last_name>
      <phone>0046722024895</phone>
      <email>sophia.brismar-wendel@sll.se</email>
    </contact>
    <contact_backup>
      <last_name>Helen Fagraeus, Midwife</last_name>
      <phone>0046812355000</phone>
      <email>helen.fagraeus@sll.se</email>
    </contact_backup>
    <investigator>
      <last_name>Sophia Brismar Wendel, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Bergendahl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria Ankarcrona, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South General Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tove Wallström, MD, PhD</last_name>
      <phone>0046737058968</phone>
      <email>tove.wallstrom@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna-Karin Nilsson Wihlbäck, M.D, PhD.</last_name>
      <email>annacarin.nilsson.wihlback@regionvasterbotten.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Jonsson, MD, Ass Prof</last_name>
      <phone>0046186115757</phone>
      <email>maria.jonsson@akademiska.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Växjö Hospital</name>
      <address>
        <city>Växjö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmie Rydström, M.D.</last_name>
      <email>emmie.rydstrom@kronoberg.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Laine K, Pirhonen T, Rolland R, Pirhonen J. Decreasing the incidence of anal sphincter tears during delivery. Obstet Gynecol. 2008 May;111(5):1053-7. doi: 10.1097/AOG.0b013e31816c4402.</citation>
    <PMID>18448735</PMID>
  </reference>
  <reference>
    <citation>Murphy DJ, Macleod M, Bahl R, Goyder K, Howarth L, Strachan B. A randomised controlled trial of routine versus restrictive use of episiotomy at operative vaginal delivery: a multicentre pilot study. BJOG. 2008 Dec;115(13):1695-702; discussion 1702-3. doi: 10.1111/j.1471-0528.2008.01960.x.</citation>
    <PMID>19035944</PMID>
  </reference>
  <reference>
    <citation>Kalis V, Laine K, de Leeuw JW, Ismail KM, Tincello DG. Classification of episiotomy: towards a standardisation of terminology. BJOG. 2012 Apr;119(5):522-6. doi: 10.1111/j.1471-0528.2011.03268.x. Epub 2012 Feb 3. Review.</citation>
    <PMID>22304364</PMID>
  </reference>
  <reference>
    <citation>de Leeuw JW, de Wit C, Kuijken JP, Bruinse HW. Mediolateral episiotomy reduces the risk for anal sphincter injury during operative vaginal delivery. BJOG. 2008 Jan;115(1):104-8. Epub 2007 Nov 12.</citation>
    <PMID>17999693</PMID>
  </reference>
  <reference>
    <citation>Räisänen SH, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Lateral episiotomy protects primiparous but not multiparous women from obstetric anal sphincter rupture. Acta Obstet Gynecol Scand. 2009;88(12):1365-72. doi: 10.3109/00016340903295626.</citation>
    <PMID>19852569</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>October 3, 2020</last_update_submitted>
  <last_update_submitted_qc>October 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Sophia Brismar Wendel</investigator_full_name>
    <investigator_title>MD, PhD, Dept of Women's health, Danderyd Hospital</investigator_title>
  </responsible_party>
  <keyword>Lateral episiotomy</keyword>
  <keyword>Obstetric anal sphincter injury</keyword>
  <keyword>Vacuum extraction</keyword>
  <keyword>Anal incontinence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Pelvic Floor Disorders</mesh_term>
    <mesh_term>Dystocia</mesh_term>
    <mesh_term>Fetal Hypoxia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized data on the primary outcome will be shared with other researchers for a joint publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>When results have been published (after 1 year).</ipd_time_frame>
    <ipd_access_criteria>Anonymized data on the primary outcome will be shared with other researchers for a joint publication.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 18, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/08/NCT02643108/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

